TSH antibody levels predict Grave’s relapse after thionamides

BOSTON – Eighty-six percent of Grave’s disease patients with TSH receptor antibody levels of at least 2.0 mU/L at the end of thionamide therapy will relapse within 4 years, according to a <a...

Source: Clinical Endocrinology News - May 1, 2016 Category: Endocrinology Source Type: news